Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers Across 15 U.S. States

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development ...

PR NewswireJul 2 09:30 ET

Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development...

PR NewswireJun 18 13:30 ET

H.C. Wainwright Maintains Co-diagnostics(CODX.US) With Hold Rating, Maintains Target Price $2

H.C. Wainwright analyst Yi Chen maintains $Co-diagnostics(CODX.US)$ with a hold rating, and maintains the target price at $2.According to TipRanks data, the analyst has a success rate of 0.0% and a to

moomoo NewsJun 17 11:31 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Neutral on Co-Diagnostics, Maintains $2 Price Target

BenzingaJun 17 10:56 ET

Express News | Co-Diagnostics Submits FDA Application For 510(k) Clearance Of Co-Dx PCR Pro Instrument And OTC COVID-19 Test; POC Clearance And Additional Tests To Follow

BenzingaJun 14 09:30 ET

Express News | Co-Diagnostics, Inc. Submits First FDA 510(K) Application for Co-Dx Pcr Pro Platform

ReutersJun 14 09:30 ET